These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 323275)

  • 41. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man.
    Scheiermann N; Baer J; Hilfenhaus J; Marcus I; Zoulek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):439-50. PubMed ID: 2445127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody and immunoglobulin response to antirabies vaccination in man.
    Cho HC; Fenje P; Sparkes JD
    Infect Immun; 1972 Oct; 6(4):483-6. PubMed ID: 4628897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
    Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
    Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on Japanese-produced chick embryo cell culture rabies vaccines.
    Arai YT; Ogata T; Oya A
    Am J Trop Med Hyg; 1991 Feb; 44(2):131-4. PubMed ID: 2012255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination of free-ranging Pennsylvania raccoons (Procyon lotor) with inactivated rabies vaccine.
    Brown CL; Rupprecht CE
    J Wildl Dis; 1990 Apr; 26(2):253-7. PubMed ID: 2338729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purified duck embryo rabies vaccine. An accelerated schedule for preexposure immunization against rabies.
    Nelson KE; Vithayasai V; MakornKawKayoon S; Batt MD; Panas-Amporn K; Anderson JT
    JAMA; 1977 Jul; 238(3):218-20. PubMed ID: 577520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250
    [No Abstract]   [Full Text] [Related]  

  • 49. Post exposure studies with human diploid cell rabies vaccine and purified chick embryo cell vaccine: comparative serological responses in man.
    Madhusudana SN; Tripathi KK
    Zentralbl Bakteriol; 1989 Sep; 271(3):345-50. PubMed ID: 2803459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the Pasteur and Pitman-Moore strains of rabies virus for the production of rabies vaccine in human diploid cells.
    Majer M; Herrmann A; Hilfenhaus J; Mauler R; Lehmann HG; Hennessen W; Kuwert EK
    J Biol Stand; 1977; 5(3):249-56. PubMed ID: 561073
    [No Abstract]   [Full Text] [Related]  

  • 51. [Quantification of levels of serum antirabies antibodies in vaccinated individuals].
    Süliová J; Benísek Z; Svrcek S; Durove A; Závadová J
    Bratisl Lek Listy; 1994 Feb; 95(2):73-7. PubMed ID: 7922630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhesus diploid rabies vaccine (adsorbed): a new rabies vaccine using FRhL-2 cells.
    Burgoyne GH; Kajiya KD; Brown DW; Mitchell JR
    J Infect Dis; 1985 Jul; 152(1):204-10. PubMed ID: 4008986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of cellular immunity to rabies antigens in human vaccinees.
    Moore SM; Wilkerson MJ; Davis RD; Wyatt CR; Briggs DJ
    J Clin Immunol; 2006 Nov; 26(6):533-45. PubMed ID: 16964551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.].
    Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA
    Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leads from the MMWR. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    JAMA; 1985 Mar; 253(11):1537, 1540. PubMed ID: 3974025
    [No Abstract]   [Full Text] [Related]  

  • 56. Rapid quantitative assay of rabies post-vaccination antibody by ELISA.
    Karamany RM; Kazar J; Malik SA; al-Mufti S; Badriya M
    APMIS Suppl; 1988; 3():40-3. PubMed ID: 3179075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
    Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
    J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody response in cattle after vaccination with inactivated and attenuated rabies vaccines.
    Rodrigues da Silva AC; Caporale GM; Gonçalves CA; Targueta MC; Comin F; Zanetti CR; Kotait I
    Rev Inst Med Trop Sao Paulo; 2000; 42(2):95-8. PubMed ID: 10810324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines.
    Albas A; Pardo PE; Gomes AA; Bernardi F; Ito FH
    Rev Soc Bras Med Trop; 1998; 31(4):367-71. PubMed ID: 9662964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
    Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.